Development of novel personalized drug therapy based on elucidation of drug sensitivity and resistance mechanism in bone and soft tissue tumors
Project/Area Number |
26713046
|
Research Category |
Grant-in-Aid for Young Scientists (A)
|
Allocation Type | Partial Multi-year Fund |
Research Field |
Orthopaedic surgery
|
Research Institution | Kyushu University (2014, 2017-2018) National Cancer Center Japan (2015-2016) |
Principal Investigator |
Endo Makoto 九州大学, 大学病院, 助教 (40713433)
|
Project Period (FY) |
2014-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥23,530,000 (Direct Cost: ¥18,100,000、Indirect Cost: ¥5,430,000)
Fiscal Year 2017: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2016: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2015: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2014: ¥7,150,000 (Direct Cost: ¥5,500,000、Indirect Cost: ¥1,650,000)
|
Keywords | 肉腫 / 薬剤耐性 / 癌 |
Outline of Final Research Achievements |
We developed sarcoma cell lines showing resistance to anticancer drugs such as doxorubicin, pazopanib and eribulin, which were widely used for bone and soft tissue sarcomas. The established drug resistant cell lines were used to analyze genes and proteins involved in drug resistance. Among them, the research using the pazopanib-resistant cell line of synovial sarcoma has succeeded in elucidating the mechanism of drug resistance and published in an English journal. In addition, we have found that HIF1α, a hypoxia-inducible factor involved in drug resistance, is a poor prognostic factor in malignant peripheral nerve sheath tumors and can be a therapeutic target. In leiomyosarcoma, we found that acquisition of drug resistance to eribulin involves overexpression of Class III β-tubulin and published in an English journal.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究成果を発展させ、臨床的な有用性が示されれば、骨軟部肉腫患者の薬物療法において、より効果を期待できる薬剤選択に有用と考えられる。また、本研究で明らかとなった薬物耐性獲得機序を阻害することに成功すれば、薬物療法の効果を長期に持続させることが可能となり、骨軟部肉腫患者の予後改善につながる可能性がある。
|
Report
(6 results)
Research Products
(65 results)
-
[Journal Article] Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line.2018
Author(s)
Yahiro K, Matsumoto Y, Fukushi JI, Kawaguchi KI, Endo M, Setsu N, IIda K, Fukushima S, Nakagawa M, Kimura A, Oda Y, Nakashima Y
-
Journal Title
Anal Cell Pathol
Volume: なし
Pages: 8987568-8987568
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Class III b-tubulin overexpression induces chemoresistance to eribulin in a leiomyosarcoma cell line.2018
Author(s)
Yahiro K, Matsumoto Y, Fukushi JI, Kawaguchi K, Endo M, Setsu N, Iida K, Fukushima S, Nakagawa M, Kimura A, Oda Y, Nakashima Y.
-
Journal Title
Analytical Cellular Pathology
Volume: 印刷中
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.2015
Author(s)
Salanti A, Clausen TM, Agerbaek M, Hedberg BJ, Mao Y, Barington L, Pereira MA, LoBello J, Endo M, Fazli L, Soden J, Wang CK, Sander AF, Dagil R, Thrane S, Holst PJ, Meng L, Favero F, Weiss GJ, Nielsen MA, Freeth J, Nielsen TO, Zaia J, Tran NL, Trent J, Babcook JS, Theander TG, Sorensen PH, Daugaard M.
-
Journal Title
Cancer Cell
Volume: 28
Issue: 4
Pages: 500-14
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas-NCIC-CTG IND 200†.2015
Author(s)
Chu QS, Nielsen TO, Alcindor T, Gupta A, Endo M, Goytain A, Xu H, Verma S, Tozer R, Knowling M, Bramwell VB, Powers J, Seymour LK, Eisenhauer EA.
-
Journal Title
Ann Oncol
Volume: 26
Issue: 5
Pages: 973-81
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
[Journal Article] Cadherin-11 regulates the metastasis of Ewing sarcoma cells to bone.2015
Author(s)
Hatano M, Matsumoto Y, Fukushi J, Matsunobu T, Endo M, Okada S, Iura K, Kamura S, Fujiwara T, Iida K, Fujiwara Y, Nabeshima A, Yokoyama N, Fukushima S, Oda Y, Iwamoto Y.
-
Journal Title
Clin Exp Metastasis.
Volume: 32
Issue: 6
Pages: 579-591
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
[Presentation] 軟骨肉腫に対するIDH変異を標的とした新規分子標的治療の開発2018
Author(s)
中川 亮, 中谷 文彦, 遠藤 誠, 川井 章, 吉田 朗彦, 八尋 健一郎, 木村 敦, 関 剛彦, 荒木 一司, 北林 一生, 中島 康晴
Organizer
第33回日本整形外科学会 基礎学術集会
Related Report
-
-
-
-
-
-
[Presentation] Treatment patterns, clinical outcomes and prognostic factors of visceral angiosarcoma (V-AS): A report from the Asian Sarcoma Consortium (ASC)2017
Author(s)
Pang A, Ngan R, Tan SH, Hirose T, Endo M, Farid M, Goh WL, Loong HH, Mingmalairak S, Chang CC, Teo S, Maw MM, Leung AKC, Chan JC, Puhaindran ME, Kawai A, Chen WW, Quek R, Sriuranpong V.
Organizer
The 42nd European Society for Medical Oncology Congress
Related Report
Int'l Joint Research
-
[Presentation] National survey of treatment of bone and soft tissue sarcoma patients in Japan : the distribution of patients and medical specialties by cancer topography and treatment modality.2017
Author(s)
Endo M, Iwamoto M, Sugawara M, Araki Y, Mori T, Shimizu K, Setsu N, Kobayashi E, Tanzawa Y, Nakatani F, Chuman H, Higashi T, Kawai A.
Organizer
The 19th International Society of Limb Salvage General Meeting
Related Report
Int'l Joint Research
-
-
-
-
[Presentation] CIC-rearranged sarcoma and BCOR-CCNB3 sarcoma: Clinical characteristics and treatment results of the newly-established “Ewing sarcoma-like” small round cell sarcomas2016
Author(s)
Endo M, Sugawara M, Yoshida A, Kobayashi E, Shimoi T, Kodaira M, Yunokawa M, Yonemori K, Tamura K, Toki S, Hirose T, Uehara T, Mori T, Shimizu K, Tanzawa Y, Nakatani F, Chuman H, Kawai A.
Organizer
The European Society for Medical Oncology Asia 2016 Annual Meeting
Place of Presentation
Singapore
Year and Date
2016-12-16
Related Report
Int'l Joint Research
-
[Presentation] Epidemiology, real world treatment and outcomes of 423 patients (pts) with angiosarcoma (AS) in Asia: A report from the Asian Sarcoma Consortium (ASC)2016
Author(s)
Quek R, Loong HH, Sriuranpong V, Farid M, Tan S, Goh W, Mingmalairak S, Chen TW, Chang C, Pang A, Teo S, Puhaindran ME, Maw M, Ngan R, Leung AK, Chan JC, Hirose T, Endo M, Kawai A.
Organizer
The European Society for Medical Oncology Asia 2016 Annual Meeting
Place of Presentation
Singapore
Year and Date
2016-12-16
Related Report
Int'l Joint Research
-
[Presentation] Optimal first line systemic therapy in patients (pts) with metastatic angiosarcoma: A report from the Asian Sarcoma Consortium2016
Author(s)
Chen TW, Pang A, Puhaindran ME, Maw M, Loong HH, Sriuranpong V, Chang C, Teo S, Mingmalairak S, Hirose T, Endo M, Kawai A, Farid M, Tan S, Goh W, Quek R, Chan JC, Leung AK, Ngan R
Organizer
The European Society for Medical Oncology Asia 2016 Annual Meeting
Place of Presentation
Singapore
Year and Date
2016-12-16
Related Report
Int'l Joint Research
-
-
[Presentation] CIC-rearranged sarcomas: clinical features and treatment outcome2016
Author(s)
Endo M, Yoshida A, Kobayashi E, Toki S, Hirose T, Uehara T, Sugawara M, Mori T, Shimizu K, Tanzawa Y, Nakatani F, Chuman H, Kawai A.
Organizer
The 21th Annual Meeting of Connective Tissue Oncology Society
Place of Presentation
Lisbon, Portuguel
Year and Date
2016-11-09
Related Report
Int'l Joint Research
-
-
[Presentation] Identification of a possible therapeutic candidate for advanced chondrosarcoma with an IDH1 mutant inhibitor2016
Author(s)
Nakagawa M, Nakatani F, Endo M, Kobayashi E, Tanzawa Y, Kawai A, Chuman H, Yoshida A, Seki T, Araki K, Iwamoto Y, Kitabayashi I
Organizer
The 21th Annual Meeting of Connective Tissue Oncology Society
Place of Presentation
Lisbon, Portuguel
Year and Date
2016-11-09
Related Report
Int'l Joint Research
-
-
-
[Presentation] Treatment of bone and soft-tissue sarcoma patients in Japan; the distribution of patients and medical specialties by cancer topography and treatment modality2016
Author(s)
Endo M, Iwamoto M, Toki S, Hirose T, Uehara T, Sugawara M, Mori T, Shimizu K, Kobayashi E, Tanzawa Y, Nakatani F, Chuman H, Higashi T, Kawai A.
Organizer
The 21th Annual Meeting of Connective Tissue Oncology Society
Place of Presentation
Lisbon, Portuguel
Year and Date
2016-11-09
Related Report
Int'l Joint Research
-
[Presentation] Clinical features, treatment and prognosis of angiosarcoma involving the spine.2016
Author(s)
Hirose T, Endo M, Yoshida A, Nakano R, Toki S, Uehara T, Sugawara M, Araki Y, Mori T, Shimizu K, Kobayashi E, Tanzawa Y, Nakatani F, Chuman H, Kawai A
Organizer
The 21th Annual Meeting of Connective Tissue Oncology Society
Place of Presentation
Lisbon, Portuguel
Year and Date
2016-11-09
Related Report
Int'l Joint Research
-
-
-
[Presentation] 軟部肉腫81例におけるpazopanibの使用経験2016
Author(s)
小林英介, 薛宇孝, 清水光樹, 菅原正登, 荒木麗博, 森智章, 中谷文彦, 遠藤誠, 丹沢義一, 川井章, 中馬広一
Organizer
第49回日本整形外科学会 骨軟部腫瘍学術集会
Place of Presentation
東京
Year and Date
2016-07-14
Related Report
-
-
-
[Presentation] Malignant glomus tumour treated with pazopanib.2015
Author(s)
Endo M, Bekki H, Kobayashi E, Tanzawa Y, Nakatani F, Kawai A, Chuman H, Oda Y, Iwamoto Y
Organizer
The European Society for Medical Oncology Asia 2015 Annual Meeting
Place of Presentation
Singapore
Year and Date
2015-12-18
Related Report
Int'l Joint Research
-
[Presentation] PTEN Expression Is A Good Prognostic Marker In Malignant Peripheral Nerve Sheath Tumors.2015
Author(s)
M. Endo, N. Setsu, E. Kobayashi, Y. Tanzawa, F. Nakatani, A. Kawai, H. Chuman, M. Hakozaki, K. Kohashi, H. Yamamoto, Y. Oda, T. Matsunobu, Y. Matsumoto, K. Harimaya, Y. Iwamoto.
Organizer
The 20th Annual Meeting of Connective Tissue Oncology Society
Place of Presentation
Salt Lake City, USA
Year and Date
2015-11-04
Related Report
Int'l Joint Research
-
-
-
-
[Presentation] A pelvic tumor.2015
Author(s)
Oda Y, Yamamoto H, Kohashi K, Endo M
Organizer
The International Skeletal Society 42nd Annual Meeting
Place of Presentation
Maui, USA
Year and Date
2015-09-26
Related Report
Int'l Joint Research
-
[Presentation] Safety and efficiency of salvage chemotherapy with ifosfamide, carboplatin and etoposide for malignant bone and soft tissue tumors.2015
Author(s)
Endo M, Hirose T, Matsunobu T, Matsumoto Y, Harimaya K, Tamura S, Kusaba H, Oda Y, Iwamoto Y.
Organizer
The Japanese Society of Medical Oncology 2015 Annual Meeting
Place of Presentation
Sapporo, Japan
Year and Date
2015-07-16
Related Report
Int'l Joint Research
-
-
[Presentation] Clinical outcome of primary leiomyosarcoma of bone(LMSOB): A multicenter study in Japan.2015
Author(s)
Mori T, Endo M, Fukase N, Hiraga H, Tomita M, Kobayashi E, Shinoda Y, Ueda T, Morioka H, Toyama Y
Organizer
The 88th Annual Meeting of the Japanese Orthopaedic Association
Place of Presentation
Kobe, Japan
Year and Date
2015-05-21
Related Report
Int'l Joint Research
-
-
-
-
-
-